Equities research analysts at StockNews.com assumed coverage on shares of Jaguar Health (NASDAQ:JAGX – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock.
Jaguar Health Price Performance
Shares of NASDAQ:JAGX opened at $0.17 on Monday. The stock’s 50-day moving average price is $0.09 and its 200-day moving average price is $0.18. Jaguar Health has a 12-month low of $0.05 and a 12-month high of $1.22. The company has a quick ratio of 1.34, a current ratio of 2.00 and a debt-to-equity ratio of 6.33.
About Jaguar Health
Further Reading
- Five stocks we like better than Jaguar Health
- Where to Find Earnings Call Transcripts
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How to Buy Cheap Stocks Step by Step
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.